Published in TZ Latest News
19 September, 2021 by The TZ Newswire Staff
Junshi Biosciences Announces Expansion of Emergency Use Authorization for Etesevimab and Bamlanivimab Administered Together to Include Post-Exposure Prophylaxis for COVID-19
SHANGHAI, China, Sept.
read more